Investigating impurities in Δ-8-THC products
Official title: Isolation and Pharmacological Evaluation of Impurities in Δ-8-THC Products
Funded at Elsohly Laboratories, INC. · NIH-11074660 · Data updated 2026-11-12
This study is looking at a cannabis compound called Δ-8-THC to find out if it has any harmful impurities and how those impurities might affect your body and behavior, so you can make safer choices about using these products.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Elsohly Laboratories, INC. NIH-funded |
| Lab location | 1 site (Oxford, United States) |
| Project start | April 15, 2024 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $228,967 |
| NIH project number | 5R21DA060394-02 |
| Project ID | NIH-11074660 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who use or are considering using Δ-8-THC products and are concerned about their safety and efficacy.
✕Less likely to help
Patients who do not use Δ-8-THC products or have no interest in cannabinoid therapies may not benefit from this research.
What this research studies
This research focuses on the minor cannabinoid Δ-8-THC, which is derived from cannabis and can be synthesized from CBD. Due to recent changes in regulations, Δ-8-THC products are widely available but may contain harmful impurities. The research aims to isolate and characterize these impurities to understand their pharmacological effects and interactions with Δ-8-THC. This will involve laboratory tests to evaluate how these impurities bind to specific receptors in the body and their potential effects on behavior.
Why it matters
Potential benefit: If successful, this research could lead to safer consumption guidelines for Δ-8-THC products and better understanding of their effects on health.
How similar studies have gone: While research on cannabinoids is ongoing, the specific focus on impurities in Δ-8-THC products is relatively novel and has not been extensively studied.
Where this research is happening
-
Elsohly Laboratories, INC.
Oxford, United States Active
Researchers
- Principal investigator: Elsohly, Mahmoud a — Elsohly Laboratories, INC.
- Study coordinator: Elsohly, Mahmoud a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.